From: Cryptosporidium and Giardia in Africa: current and future challenges
Country | Patient group | Cryptosporidium species (Prevalence in %)a | gp60 subtypes | Reference |
---|---|---|---|---|
Botswana | Children with diarrhoea (< 5 years) | C. parvum (50.0) | [41] | |
C. hominis (41.0) | ||||
Côte d’Ivoire | Individuals with intestinal disorders | C. meleagridis (75.0) | [106] | |
C. parvum (16.7) | ||||
C. hominis (8.3) | ||||
Democratic Republic of Congo | HIV-infected adults | C. hominis (80.0) | [28] | |
C. parvum (20.0) | ||||
Egypt | Individuals with livestock in their household | C. hominis (75.0) | [108] | |
C. parvum (25.0) | IIdA20G1 | |||
Egypt | Children with diarrhoea (≤ 10 years) | C. hominis (60.5) | [26] | |
C. parvum (38.3) | ||||
Egypt | Diarrhoeal patients | C. hominis (97.0) | [131] | |
C. parvum (3.0) | ||||
Egypt | Children with diarrhoea (1–14 years) | C. parvum (82.0) | [290] | |
C. hominis (12.0) | ||||
Mixed infections (6.0) | ||||
Egypt | Children with diarrhoea (< 10 years) | C. hominis (60.5) | [95] | |
C. parvum (38.3) | IIaA15G1R1; IIaA15G2R1; IIdA20G1a | |||
C. parvum + C. bovis (1.2) | ||||
Egypt | Diarrhoeal patients | C. hominis (60.0) | [105] | |
C. parvum (20.0) | ||||
C. hominis + C. parvum (20.0) | ||||
Egypt | Gastrointestinal symptomatic patients | C. parvum (66.7) | [156] | |
C. hominis (27.7) | ||||
C. meleagridis (5.6) | ||||
Egypt | Immunocompromised patients | C. parvum (68.4) | [349] | |
C. hominis (26.3) | ||||
C. parvum + C. hominis (5.3) | ||||
Equatorial Guinea | HIV-infected and immunocompetent patients | C. parvum (52.9) | [150] | |
C. hominis (44.1) | ||||
C. meleagridis (2.9) | ||||
Equatorial Guinea | HIV-seropositive patients | C. parvum (54.8) | IIcA5G3b; IIeA10G1 | [152] |
C. hominis (50.0) | IaA18R3b; IaA24R3; IbA13G3; IdA15; IdA18b | |||
C. meleagridis (3.2) | ||||
Ethiopia | Diarrhoeal patients (14–71 years) | C. parvum (95.1) | IIaA15G2R1b; IIaA16G2R1; IIaA16G1R1 | [82] |
C. hominis (2.4) | IbA9G3 | |||
C. hominis + C. parvum (2.4) | ||||
Ethiopia | HIV/AIDS patients | C. parvum (65.7) | IIaA13G2R1; IIaA14G2R1; IIaA15G2R1b; IIaA16G2R1; IIaA16G3R1; IIaA17G2R1; IIaA18G2R1; IIaA19G1R; IIbA12; IIcA5G3a; IIdA17G1; IIdA19G1; IIdA22G1; IIdA24G1; IIeA12G1; If-like | [23] |
C. hominis (17.9) | IbA10G2; IdA20b; IdA24; IdA26; IeA11G3T3 | |||
C. viatorum (7.1) | ||||
C. felis (3.6) | ||||
C. meleagridis (2.1) | ||||
C. canis (1.4) | ||||
C. xiaoi (1.4) | ||||
C. hominis + C. parvum (0.7) | ||||
Ethiopia | Patients | C. hominis (100) | IbA9G3 | [99] |
Ethiopia | Cryptosporidium-positive (7 months to 27 years) | C. viatorum (90.0) | XVaA3d | [161] |
Ethiopia | Children (6–15 years) | C. hominis (40.0) | [103] | |
C. viatorum (40.0) | ||||
C. parvum (20.0) | ||||
Ghana | Children (≤ 5 years) | C. parvum (100) | [142] | |
Ghana | Children with and without gastrointestinal symptoms | C. hominis (58.0) | IaA15T1R3; IaA15G1R4; IaA17; IaA18R3; IaA19R3; IaA21R3; IaA22R3; IaA24R3; IbA13G3b; IdA15; IeA11G3T3 | [98] |
C. parvum (42.1) | IIcA5G3ab; IIcA5G3b; IIeA10G1; IIeA10G2 | |||
Kenya | HIV patients | C. hominis (66.7) | [146] | |
C. parvum (16.7) | ||||
C. meleagridis (16.7) | ||||
Kenya | Not stated | C. hominis (C. parvum human) (90.0) | Ib; Ieb | [155] |
C. meleagridis (10.0) | ||||
Kenya | An HIV-infected adult with diarrhoea | C. muris “rock hyrax” | [139] | |
Kenya | HIV-positive and negative children and adults | C. parvum human (69.7) | [147] | |
C. parvum bovine (21.2) | ||||
C. meleagridis (3.0) | ||||
C. muris (3.0) | ||||
Kenya | Children (< 5 years) | C. hominis (87.4) | [129] | |
C. parvum (8.6) | ||||
C. canis (1.7) | ||||
C. felis (1.1) | ||||
C. muris (0.6) | ||||
C. meleagridis (0.6) | ||||
Kenya | Children (≤ 5 years) | C. hominis (82.1) | [88] | |
C. parvum (17.9) | ||||
Kenya | HIV/AIDS patients with and without diarrhoea (≥ 18 years) | C. hominis (60.7) | Ia; Ibb; Id; Ie; If | [25] |
C. parvum (23.2) | IIab; IIb; IIeb; IIc | |||
C. canis (7.1) | ||||
C. meleagridis (5.3) | ||||
C. suis (3.6) | ||||
Kenya | HIV infected and uninfected children (5 years) | C. hominis (82.8) | IaA25R5; IaA27R3; IaA30R3; IaA7R1; IbA9G3; IbA9G3R2; IdA22; IdA24; IdA19; IdA25; IdA21; IdA20; IdA17G1; IdA18; IdA15G1; IdA23G1; IeA11G3T3R1b; IeA11G3T3; IfA19G1; IfA14G1; IfA12G1 | [115] |
C. parvum (11.9) | IIcA5G3R2 | |||
C. felis (2.6) | ||||
C. meleagridis (1.3) | ||||
C. parvum + C. hominis (0.7) | ||||
Kenya | Cryptosporidium spp.-positive female (25 years) | C. viatorum | XVaA3d | [161] |
Kenya | Children (≤ 5 years) | C. hominis (38.9) | [153] | |
C. parvum (36.1) | ||||
C. meleagridis (16.7) | ||||
C. canis (5.6) | ||||
Unknown genotype (2.8) | ||||
Madagascar | Children with acute diarrhoeal disease (≤ 16 years) | C. hominis (91.7) | IaA22R3; IdA15G1b; IeA11G3T3 | [350] |
C. parvum (8.3) | IIcA5G3 | |||
Madagascar | Humans from rural south-eastern Madagascar | C. suis (100) | [97] | |
Malawi | HIV-positive and negative children | C. hominis (63.6) | [147] | |
C. parvum (36.4) | ||||
Malawi | Children HIV-positive and seronegative (≤ 30 months) | C. hominis (95.3) | Ia; Ib; Idb; Ie | [351] |
C. parvum (4.7) | IIc; IIe | |||
Malawi | Diarrhoeal children (< 5 years) | C. hominis (58.1) | [149] | |
C. parvum (23.3) | ||||
C. parvum + C. hominis (2.3) | ||||
C. parvum/C. hominis (9.3) | ||||
C. meleagridis (4.7) | ||||
C. muris/C. andersoni (2.3) | ||||
Nigeria | HIV-infected (majority) and non-infected patients | C. hominis (47.2) | IaA14R3; IaA16R3; IaA24R3; IaA25R3; IbA13G3; IeA11T3G3b | [83] |
C. parvum (44.4) | IIcA5G3a; IIcA5G3h; New subtype family 1b; New subtype family 2 | |||
C. felis (5.6) | ||||
C. canis (2.8) | ||||
Nigeria | Children (6 months to 6 years) | C. hominis (44.2) | IaA18R2; IaA22R2; IaA24R2; IaA25R2; IaA28R2; IaA21R1; IbA10G2; IbA13G3b; IdA11; IdA17; IeA11G3T3b; Ih (Novel subtype); IhA14G1 | [141] |
C. parvum (32.5) | IIaA15G2R1; IIaA16G1R1; IIcA5G3ab; IIcA5G3b; IIiA11; IImA14G1 | |||
C. parvum plus C. hominis (5.2) | ||||
C. meleagridis (6.5) | ||||
C. cuniculus (C. rabbit genotype) (6.5) | ||||
C. ubiquitum (C. cervine genotype) (3.9) | ||||
C. canis (1.3) | ||||
Nigeria | Children (19.5–72 months) | C. hominis (37.3) | [86] | |
C. parvum (35.3) | ||||
C. parvum + C. hominis (7.8) | ||||
C. meleagridis (7.8) | ||||
C. cuniculus (C. rabbit genotype) (3.9) | ||||
C. ubiquitum (C. cervine genotype) (2.0) | ||||
C. canis (2.0) | ||||
Nigeria | Diarrhoeal and non-diarrhoeal children (1 to > 12 months) | C. hominis (60.0) | IaA24R3b; IbA13G3 | [87] |
C. parvum (40.0) | IIcA5G3k | |||
Nigeria | Patients (2 months to 70 years) | C. hominis (66.7) | IaA23R3; IaA25R3 | [166] |
C. parvum (33.3) | IIeA10G1 | |||
Nigeria | HIV-infected patients (22–65 years) | C. hominis (50.0) | IeA11G3T3 | [101] |
C. parvum (25.0) | IIcA5G3k | |||
C. meleagridis + C. hominis (25.0) | ||||
São Tomé and Príncipe | Children (2 months to 10 years) | C. hominis (73.7) | IeA11G3T3R1; IeA11G3T3; IaA27R3b; IaA23R3 | [96] |
C. parvum (26.3) | IIdA21G1a; IIdA26G1b; IIaA16G2R1; IIaA15G2R1 | |||
South Africa | Children (< 5 years) | C. hominis (75.0) | IbA12G3R2; IbA10G2; IeA11G3T3 | [154] |
C. meleagridis (25.0) | ||||
South Africa | Children (< 5 years) | C. hominis (76.0) | IaA20R3; IaA25G1R3; IaA17R3; IbA9G3; IbA10G1; IdA20; IdA25IdA26; IdA24; IeA11G3T3b; IfA14G1; IfA12G1 | [89] |
C. parvum (20.0) | IIbA11; IIcA5G3bb; IIeA12G1 | |||
C. meleagridis (4.0) | IIIdA4 | |||
South Africa | School children and hospital patients (≤ 88 years) | C. hominis (81.8) | [77] | |
C. parvum (18.2) | ||||
South Africa | HIV-infected children | C. hominis (75.0) | Ia; Ib; Id; Ie | [352] |
C. parvum (25.0) | IIc | |||
Tanzania | People living in and around Gombe National Park | C. hominis (100) | IfA12G2 | [102] |
Tanzania | Diarrhoeal children and controls (< 2 years old) | C. hominis (84.7) | [72] | |
C. parvum (7.6) | ||||
C. parvum or C. hominis (7.6) | ||||
Tanzania | HIV patients (18–65 years) | C. hominis (71.4) | [162] | |
C. parvum (28.6) | ||||
Tunisia | Children (< 5 years old) | C. parvum (57.1) | IIaA15G2R1b; IIdA16G1 | [114] |
C. meleagridis (42.9) | ||||
Tunisia | Children with primary immune deficiencies | C. hominis (40.0) | [151] | |
C. parvum (20.0) | ||||
C. meleagridis (20.0) | ||||
C. hominis/C. meleagridis (20.0) | ||||
Tunisia | Immunocompetent and immunodeficiency children | C. parvum (42.1) | [140] | |
C. hominis (36.8) | ||||
C. meleagridis (21.1) | ||||
Uganda | Volunteers (1.9 months to 75 years) | C. parvum (97.1) | [107] | |
C. parvum or C. hominis or C. cuniculus (2.9) | ||||
Uganda | Children (2–84 months) | C. hominis (74.4) | Ia; Ib; Id; Ieb | [148] |
C. parvum (18.3) | IIcb; IIg; IIh; Iii | |||
C. hominis + C. parvum (3.7) | ||||
C. meleagridis (3.7) | ||||
Uganda | Children with persistent diarrhoea, with and without HIV/AIDS (< 6 months) | C. hominis (73.7) | [70] | |
C. parvum (18.4) | ||||
C. parvum + C. hominis (3.9) | ||||
C. meleagridis (3.9) | ||||
Uganda | People who share habitats with free-ranging gorillas | C. parvum (100) | [191] | |
Zambia | Dairy farm workers and their household members | C. parvum (80.0) | [118] | |
C. hominis (20.0) |